Market Overview

Stocks Hitting 52-Week Highs

Share:
Related ARNA
Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research
Jefferies: 10 Buyout Targets To Own During The M&A Boom
Orexigen: Contrave Sales Pop, Equity Response Muted (Seeking Alpha)
Related HSIC
Atossa Genetics Soars On Distribution Pact With Henry Schein
Top 4 Stocks In The Medical Equipment Wholesale Industry With The Highest EPS Growth Forecast For Next Year

Arena Pharmaceuticals (NASDAQ: ARNA) shares jumped 8.10% to create a new 52-week high of $9.08. The Food and Drug Administration is scheduled to make a decision on the company's experimental obesity drug lorcaserin by June 27.

Henry Schein (NASDAQ: HSIC) shares gained 1.14% to touch a new 52-week high of $78.71. Henry Schein's PEG ratio is 1.51.

Cerner (NASDAQ: CERN) shares rose 3.59% to create a new 52-week high of $85.61. Cerner and Corniche Hospital introduced the positive patient identification program to improve patient health outcomes and safety.

Smart Balance (NASDAQ: SMBL) shares gained 3.25% to create a new 52-week high of $8.26. Smart Balance shares have jumped 50.38% over the past 52 weeks, while the S&P 500 index has gained 5.61% in the same period.

Posted-In: 52-Week HighsNews Intraday Update Markets Movers

 

Related Articles (ARNA + CERN)

Around the Web, We're Loving...